AMSTERDAM & BOSTON & SEATTLE, September 18, 2025--(BUSINESS WIRE)--VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of ...
VectorY gains exclusive rights to evaluate and potentially license SHP-DB1, enhancing its neurodegenerative disease therapy pipeline. SHP-DB1, an engineered AAV5 capsid, offers improved brain ...
Vector images are images that are expressed as a collection of shapes such as circles and straight lines, and are widely used in the design field because they allow for advanced editing of size and ...